Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease

被引：0
|
作者：
Chao-Ping Wang
Chia-Chang Hsu
Wei-Chin Hung
Teng-Hung Yu
Cheng-Ching Wu
I-Ting Tsai
Wei-Hua Tang
Fu-Mei Chung
Jer-Yiing Houng
Yau-Jiunn Lee
Yung-Chuan Lu
机构：
[1] I-Shou University,Division of Cardiology
[2] I-Shou University,Division of Gastroenterology and Hepatology
[3] E-Da Hospital,Division of Endocrinology and Metabolism, Department of Internal Medicine
[4] I-Shou University,Department of Emergency
[5] E-Da Hospital,Division of Cardiology, Department of Internal Medicine
[6] I-Shou University,Department of Nutrition, Institute of Biotechnology and Chemical Engineering
[7] National Yang-Ming University Hospital,undefined
[8] School of Medicine for International Students,undefined
[9] College of Medicine,undefined
[10] I-Shou University,undefined
[11] College of Medicine,undefined
[12] I-Shou University,undefined
[13] Lee’s Endocrinologic Clinic,undefined
来源：
BMC Cardiovascular Disorders | / 19卷
关键词：
Fatty acid-binding protein 4; Stable angina; Chronic kidney disease; QTc interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Maternal Serum Fatty Acid Binding Protein 4 (FABP4) and the Development of Preeclampsia
    Scifres, Christina M.
    Catov, Janet M.
    Simhan, Hyagriv
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : E349 - E356
  • [22] Markers of metabolic syndrome: Role of fatty acid binding protein 4 (FABP4)
    Alegret, Marta
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (06): : 256 - 258
  • [23] Fatty acid binding protein 4 (FABP4) and the development of pre-eclampsia
    Scifres, Christina
    Simhan, Hyagriv
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S293 - S293
  • [24] Common FABP4 Genetic Variants and Plasma Levels of Fatty Acid Binding Protein 4 in Older Adults
    Mukamal, Kenneth J.
    Wilk, Jemma B.
    Biggs, Mary L.
    Jensen, Majken K.
    Ix, Joachim H.
    Kizer, Jorge R.
    Tracy, Russell P.
    Zieman, Susan J.
    Mozaffarian, Dariush
    Psaty, Bruce M.
    Siscovick, David S.
    Djousse, Luc
    LIPIDS, 2013, 48 (11) : 1169 - 1175
  • [25] Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against renal ischemia-reperfusion injury
    Shi, Min
    Huang, Rongshuang
    Guo, Fan
    Li, Lingzhi
    Feng, Yanhuan
    Wei, Zhengjie
    Zhou, Li
    Ma, Liang
    Fu, Ping
    RSC ADVANCES, 2018, 8 (27): : 15207 - 15214
  • [26] Unconventional Secretion of Adipocyte Fatty Acid Binding Protein (FABP4) by Adipocytes
    Josephrajan, Ajeetha
    Hertzel, Ann V.
    Mashek, Douglas
    Kim, Do-Hyung
    Imai, Shin-Ichiro
    Bernlohr, David A.
    FASEB JOURNAL, 2018, 32 (01):
  • [27] INHIBITION OF FATTY ACID BINDING PROTEIN-4 (FABP4) ALLEVIATES HYPERURICEMIC NEPHROPATHY
    Ma, Liang
    Shi, Min
    Fu, Ping
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [28] Expression and significance of Fatty acid binding protein 4(FABP4) in acute coronary syndrome
    Sun, Yanzhuan
    Xu, Yiguan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C90 - C91
  • [29] Fatty Acid Binding Protein 4, FABP4, Causes Impaired Wound Healing in Diabetes
    Boniakowski, Anna
    Kimball, Andrew
    Davis, Frank
    Joshi, Amrita
    Schaller, Matt
    denDekker, Aaron
    Kunkel, Steve
    Gallagher, Katherine
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [30] Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury
    Obajdin, Jana
    Cotter, Mabel
    Snelling, Sara
    Dremier, Sarah
    De Ron, Pierrette
    Fleurance, Renaud
    Valentin, Jean-Pierre
    da Costa, Andre Nogueira
    Gryshkova, Vitalina
    TOXICOLOGICAL SCIENCES, 2018, 166 (02) : 441 - 450
12345